Cytomx share price
 & Stoke Therapeutics …)
WebCytomX Therapeutics, Inc. (CTMX) NasdaqGS - NasdaqGS Real Time Price. Currency in USD Follow 2W 10W 9M 1.5600 +0.0700 (+4.70%) At close: 04:00PM EDT 1.5800 … Find the latest CytomX Therapeutics, Inc. (CTMX) stock discussion in Yahoo … Discover historical prices for CTMX stock on Yahoo Finance. View daily, weekly or … See CytomX Therapeutics, Inc. (CTMX) Environment, Social and Governance … Find out the direct holders, institutional holders and mutual fund holders for … CytomX Therapeutics, Inc. (CTMX) NasdaqGS - NasdaqGS Real Time … Interactive Chart for CytomX Therapeutics, Inc. (CTMX), analyze all the data with a … See CytomX Therapeutics, Inc. (CTMX) stock analyst estimates, including … Get the latest CytomX Therapeutics, Inc. (CTMX) stock news and headlines to … The latest news and headlines from Yahoo! News. Get breaking news stories and in … At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio … WebApr 14, 2024 · Komo Plant Based Foods Inc. (OTCMKTS:KOMOF – Get Rating)’s share price traded down 4.1% during trading on Thursday .The stock traded as low as $0.09 and last traded at $0.13. 5,153 shares ...
Cytomx share price
Did you know?
WebNov 17, 2024 · That trading point still is far off CytomX's 52-week high of $7.46 per share, but the rise indicates Wall Street's belief that CytomX is heading in the right direction with its third... Web18 hours ago · Price To Free Cash Flow is a widely used stock evaluation measure. Find the latest Price To Free Cash Flow for CytomX Therapeutics (CTMX)
WebFeb 7, 2024 · Take a more thorough look at CytomX Therapeutics' financial health with this free report on its balance sheet. A Different Perspective. While the broader market lost about 9.4% in the twelve months, CytomX Therapeutics shareholders did even worse, losing 37%. However, it could simply be that the share price has been impacted by broader market ... WebMar 27, 2024 · CytomX Therapeutics (CTMX) came out with a quarterly loss of $0.42 per share versus the Zacks Consensus Estimate of a loss of $0.21. This compares to loss of $0.40 per share a year ago. These...
WebPrice trends tend to persist, so it's worth looking at them when it comes to a share like CytomX Therapeutics. Over the past six months, its share price has outperformed the S&P500 Index by +35.14%. As of the last closing price of $2.10, shares in CytomX Therapeutics were trading +19.96% higher than their 200 day moving WebApr 6, 2024 · Share . Today's Range ... Short selling CTMX is an investing strategy that aims to generate trading profit from CytomX Therapeutics as its price is falling. CTMX shares are trading up $0.07 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short ...
WebCTMX : 1.5200 (-15.08%) FATE : 5.27 (-3.83%) GRPH : 2.45 (+1.24%) COST : 486.77 (-1.31%) SPRB : 2.26 (-2.38%) WWE : 87.98 (+0.70%) More news for this symbol Day …
WebApr 6, 2024 · CytomX Therapeutics (CTMX) (Delayed Data from NSDQ) $1.56 USD +0.07 (4.70%) Updated Apr 6, 2024 04:00 PM ET After-Market: $1.57 +0.01 (0.64%) 7:58 PM … phitz ukulele hard caseWebApr 3, 2024 · Complete CytomX Therapeutics Inc. stock information by Barron's. View real-time CTMX stock price and news, along with industry-best analysis. phitz keyboard dust coverWebCTMX Stock 12 Months Forecast $2.48 (64.24% Upside) Based on 4 Wall Street analysts offering 12 month price targets for CytomX Therapeutics in the last 3 months. The … phitz diseaseWebApr 14, 2024 · Shares of NASDAQ:CTMX opened at $1.73 on Friday. CytomX Therapeutics has a 12 month low of $1.17 and a 12 month high of $3.02. The business’s 50 day … phityriases versidWebCytomX Therapeutics stock price target cut to $4 from $16 at Mizuho Jul. 7, 2024 at 7:08 a.m. ET by Tomi Kilgore CytomX Therapeutics downgraded to neutral from buy at … ts shara fabricanteWebMotley Fool. CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company in the United States. The company develops antibody … phi\u0026p facebookWebIn the last trading session, 1.97 million shares of the CytomX Therapeutics Inc. (NASDAQ:CTMX) were traded, and its beta was 0.60. Most recently the company’s … phitz cases